Patienter, der fik Zometa, indberettede mindre stigning i smerter end patienter, der fik placebo, og forskellen nåede signfikansniveauet ved måned 3, 9, 21 og 24.
Patients receiving Zometa reported less increase in pain than those receiving placebo, and the difference reached significance at months 3, 9, 21 and 24.